Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
Quantum Surgical SAS is a robotics company founded 2017, based in France, developing 1 robot primarily in the Surgical / Medical category.
CAPITAL & EVIDENCE
Quantum Surgical SAS has raised US$48.7M across 2 confirmed rounds and has 2 cited customers but no deployment on record.
Raised
US$48.7M
across 2 confirmed rounds · latest Oct 2021
- Oct 2021· US$46.4M· led by Ally Bridge Group· ActuIA ↗
- Mar 2020· US$2.3M· investors: Bpifrance bank· BioWorld News ↗
Confirmed rounds recorded from January 2017. Every amount links to its source.
Correct this →Shipped
2customers cited
named in public sources · no deployment on record
- Léon Bérard Centerquantumsurgical.com ↗
- Toulouse University Hospitalsurgicalroboticstechnology.com ↗
A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against Quantum Surgical SAS.
In Surgical / Medical, CMR Surgical, BD Rowa and Catalia Health have deployment evidence on file.
Add a deployment →Medical robotics and AI for minimally invasive cancer treatment
Quantum Surgical is a French medical robotics company that develops Epione, a robotic platform for minimally invasive interventional oncology, with a focus on liver cancer treatment and related tumor ablation workflows. The company is based in Montpellier, France, was co-founded in 2017, and reports operations in clinical adoption across Europe and the U.S.
Active products
1
RoboIndex
31.02
RoboScore 31.02 + Momentum 0.00
Company facts
- HQ
- Montpellier, France
- Founded
- 2017 · 9 yrs
- Employees
- 130
- Website
- www.quantumsurgical.com
RoboScore
31.02 RoboScore + 0.00 Momentum· Weak evidence
Products, Range, Traction set the number — the three factors present for every company. Activity, Attention, Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
6 of 6 factors known. How it's calculated
Awards & recognition
- Prix Galien nomineefrenchhealthcare.com ↗
Milestones
Quantum Surgical announced FDA 510(k) clearance for Epione, enabling U.S. commercialization.
A first-in-human pilot study evaluated EPIONE for CT-guided percutaneous needle insertion in liver tumor ablation.
The European Investment Bank announced a €15 million loan to support commercial launch of Epione.
Quantum Surgical said it was co-founded in 2017 by Bertin Nahum.
Press coverage
- FDA clears Quantum Surgical's liver-cancer-focused ablation robot
Fierce Biotech
- Quantum Surgical's Epione Robot for Cancer Treatment Receives FDA Clearance
EV Today · Mar 2022
- Quantum Surgical secures FDA nod for cancer treatment device Epione
NS Medical Devices
- France: EIB lends €15 million to Quantum Surgical for the launch of Epione
EIB · Dec 2021
- The Toulouse University Hospital Acquires Epione® Robot
Surgical Robotics Technology
Active products by Quantum Surgical SAS
1 shown| # | Category | Key specs | ||||
|---|---|---|---|---|---|---|
| 1 |  | Epione | Surgical / Medical | DOF 6 DOF | 2017 | 36.2 |
Surgical / Medical buying guides
Industry Knowledge →
Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle
A surgical robot purchased today will be in your OR for 10–15 years. The support SLA, software upgrade path, end-of-life timeline, and field service model deter…
Pilot to Scale: Case Volume Thresholds for Surgical Robot ROI
Most surgical robot programs break even somewhere between 150 and 400 cases per year depending on platform, procedure mix, and reimbursement. The math is knowab…
Surgeon Training Curve and Proctoring: The 18-Month Onboarding Window
A surgeon's robotic learning curve runs 20–150 cases depending on procedure and prior experience. The proctoring structure, credentialing ladder, and OR efficie…